{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:47:33Z","timestamp":1776692853401,"version":"3.51.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["AGL2013-45110-R"],"award-info":[{"award-number":["AGL2013-45110-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI081692"],"award-info":[{"award-number":["PI081692"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01857"],"award-info":[{"award-number":["PI15\/01857"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RETICEF"],"award-info":[{"award-number":["RETICEF"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBERFES"],"award-info":[{"award-number":["CIBERFES"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["Ayudas de Intensificaci\u00f3n de la Investigaci\u00f3n"],"award-info":[{"award-number":["Ayudas de Intensificaci\u00f3n de la Investigaci\u00f3n"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["Grupo CTS413"],"award-info":[{"award-number":["Grupo CTS413"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00223-019-00533-0","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T06:34:49Z","timestamp":1549434889000},"page":"631-640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Proof of Concept on Functionality Improvement of Mesenchymal Stem-Cells, in Postmenopausal Osteoporotic Women Treated with Teriparatide (PTH1-34), After Suffering Atypical Fractures"],"prefix":"10.1007","volume":"104","author":[{"given":"Antonio","family":"Casado-D\u00edaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Dorado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Giner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Navarro-Valverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"D\u00edez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Quesada-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"533_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.18.2323","volume":"285","author":"A Klibanski","year":"2001","unstructured":"Klibanski A, Adams-Campbell L, Bassford T et al (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785\u2013795","journal-title":"JAMA"},{"key":"533_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/gerona\/glt093","volume":"68","author":"JA Cauley","year":"2013","unstructured":"Cauley JA (2013) Public health impact of osteoporosis. J Gerontol Ser A 68:1243\u20131251. \n                    https:\/\/doi.org\/10.1093\/gerona\/glt093","journal-title":"J Gerontol Ser A"},{"key":"533_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ecl.2012.04.007","volume":"41","author":"DL Diab","year":"2012","unstructured":"Diab DL, Watts NB (2012) Bisphosphonates in the treatment of osteoporosis. Endocrinol Metab Clin North Am 41:487\u2013506. \n                    https:\/\/doi.org\/10.1016\/j.ecl.2012.04.007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"533_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00198-012-2068-9","volume":"24","author":"N Freemantle","year":"2013","unstructured":"Freemantle N, Cooper C, Diez-Perez A et al (2013) Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int 24:209\u2013217. \n                    https:\/\/doi.org\/10.1007\/s00198-012-2068-9","journal-title":"Osteoporos Int"},{"key":"533_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","volume":"84","author":"KA Kennel","year":"2009","unstructured":"Kennel KA, Drake MT (2009) Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 84:632\u2013638. \n                    https:\/\/doi.org\/10.1016\/S0025-6196(11)60752-0","journal-title":"Mayo Clin Proc"},{"key":"533_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American society for bone and mineral research. J Bone Miner Res 29:1\u201323. \n                    https:\/\/doi.org\/10.1002\/jbmr.1998","journal-title":"J Bone Miner Res"},{"key":"533_CR7","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1056\/NEJMc1612804","volume":"376","author":"N Roca-Ayats","year":"2017","unstructured":"Roca-Ayats N, Balcells S, Garcia-Giralt N et al (2017) GGPS1 mutation and atypical femoral fractures with bisphosphonates. N Engl J Med 376:1794\u20131795. \n                    https:\/\/doi.org\/10.1056\/NEJMc1612804","journal-title":"N Engl J Med"},{"key":"533_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bonr.2017.01.002","volume":"6","author":"HH Nguyen","year":"2017","unstructured":"Nguyen HH, Milat F, Ebeling PR (2017) Bone Reports Case Report A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate. Bone Rep 6:34\u201337. \n                    https:\/\/doi.org\/10.1016\/j.bonr.2017.01.002","journal-title":"Bone Rep"},{"issue":"Suppl 1","key":"533_CR9","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/S0020-1383(13)70013-5","volume":"44","author":"L Pietrogrande","year":"2013","unstructured":"Pietrogrande L, Raimondo E (2013) Teriparatide in the treatment of non-unions: scientific and clinical evidences. Injury 44(Suppl 1):S54\u2013S57. \n                    https:\/\/doi.org\/10.1016\/S0020-1383(13)70013-5","journal-title":"Injury"},{"key":"533_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5152\/eurjrheum.2015.0010","volume":"3","author":"SR Mastaglia","year":"2016","unstructured":"Mastaglia SR, Aguilar G, Oliveri B (2016) Teriparatide for the rapid resolution of delayed healing of atypical fractures associated with long-term bisphosphonate use. Eur J Rheumatol 3:87\u201390. \n                    https:\/\/doi.org\/10.5152\/eurjrheum.2015.0010","journal-title":"Eur J Rheumatol"},{"key":"533_CR11","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","volume":"40","author":"RL Jilka","year":"2007","unstructured":"Jilka RL (2007) Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40:1434\u20131446. \n                    https:\/\/doi.org\/10.1016\/j.bone.2007.03.017","journal-title":"Bone"},{"key":"533_CR12","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/jbmr.1665","volume":"27","author":"SW Kim","year":"2012","unstructured":"Kim SW, Pajevic PD, Selig M et al (2012) Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. J Bone Miner Res 27:2075\u20132084. \n                    https:\/\/doi.org\/10.1002\/jbmr.1665","journal-title":"J Bone Miner Res"},{"key":"533_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/B978-0-12-801238-3","volume-title":"Reference module in biomedical sciences. Biochemistry, cell biology and molecular biology","author":"A Casado-D\u00edaz","year":"2016","unstructured":"Casado-D\u00edaz A, Quesada-G\u00f3mez JM, Dorado G (2016) Stem cell research and molecular markers in medicine. In: Caplan M (ed) Reference module in biomedical sciences. Biochemistry, cell biology and molecular biology. Elsevier, Amsterdam, p 14. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-801238-3"},{"key":"533_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00277-012-1438-x","volume":"91","author":"M Zaim","year":"2012","unstructured":"Zaim M, Karaman S, Cetin G, Isik S (2012) Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann Hematol 91:1175\u20131186. \n                    https:\/\/doi.org\/10.1007\/s00277-012-1438-x","journal-title":"Ann Hematol"},{"key":"533_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1474-9728.2004.00127.x","volume":"3","author":"EJ Moerman","year":"2004","unstructured":"Moerman EJ, Teng K, Lipschitz D, Lecka-Czernik B (2004) Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma\/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta\/BMP signaling pathways. Aging Cell 3:379\u2013389. \n                    https:\/\/doi.org\/10.1111\/j.1474-9728.2004.00127.x","journal-title":"Aging Cell"},{"key":"533_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.01.014","volume":"85","author":"L Singh","year":"2016","unstructured":"Singh L, Brennan TA, Russell E et al (2016) Aging alters bone-fat reciprocity by shifting in vivo mesenchymal precursor cell fate towards an adipogenic lineage. Bone 85:29\u201336. \n                    https:\/\/doi.org\/10.1016\/j.bone.2016.01.014","journal-title":"Bone"},{"key":"533_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/14653240802192644","volume":"10","author":"A Casado-D\u00edaz","year":"2008","unstructured":"Casado-D\u00edaz A, Santiago-Mora R, Jim\u00e9nez R et al (2008) Cryopreserved human bone marrow mononuclear cells as a source of mesenchymal stromal cells: application in osteoporosis research. Cytotherapy 10:460\u2013468. \n                    https:\/\/doi.org\/10.1080\/14653240802192644","journal-title":"Cytotherapy"},{"key":"533_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00198-011-1666-2","volume":"23","author":"P D\u2019Amelio","year":"2012","unstructured":"D\u2019Amelio P, Tamone C, Sassi F et al (2012) Teriparatide increases the maturation of circulating osteoblast precursors. Osteoporos Int 23:1245\u20131253. \n                    https:\/\/doi.org\/10.1007\/s00198-011-1666-2","journal-title":"Osteoporos Int"},{"key":"533_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4252\/wjsc.v6.i5.637","volume":"6","author":"BC Huber","year":"2014","unstructured":"Huber BC (2014) Impact of parathyroid hormone on bone marrow-derived stem cell mobilization and migration. World J Stem Cells 6:637. \n                    https:\/\/doi.org\/10.4252\/wjsc.v6.i5.637","journal-title":"World J Stem Cells"},{"key":"533_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/jcp.21976","volume":"222","author":"G Bernardo Di","year":"2010","unstructured":"Di Bernardo G, Galderisi U, Fiorito C et al (2010) Dual role of parathyroid hormone in endothelial progenitor cells and marrow stromal mesenchymal stem cells. J Cell Physiol 222:474\u2013480. \n                    https:\/\/doi.org\/10.1002\/jcp.21976","journal-title":"J Cell Physiol"},{"key":"533_CR21","doi-asserted-by":"publisher","unstructured":"Feron J-M, Cambon-Binder A (2017) Medication management after intramedullary nailing of atypical fractures. Injury 48 Suppl 1:S15\u2013S17. \n                    https:\/\/doi.org\/10.1016\/j.injury.2017.04.030","DOI":"10.1016\/j.injury.2017.04.030"},{"key":"533_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420. \n                    https:\/\/doi.org\/10.1007\/s00198-010-1501-1","journal-title":"Osteoporos Int"},{"key":"533_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jbmr.1731","volume":"28","author":"RC G\u00fcerri-Fern\u00e1ndez","year":"2013","unstructured":"G\u00fcerri-Fern\u00e1ndez RC, Nogu\u00e9s X, Quesada G\u00f3mez JM et al (2013) Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. J Bone Miner Res 28:162\u2013168. \n                    https:\/\/doi.org\/10.1002\/jbmr.1731","journal-title":"J Bone Miner Res"},{"key":"533_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00198-018-4520-y","volume":"29","author":"JM Quesada-Gomez","year":"2018","unstructured":"Quesada-Gomez JM, Bouillon R (2018) Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos Int 29:1697\u20131711. \n                    https:\/\/doi.org\/10.1007\/s00198-018-4520-y","journal-title":"Osteoporos Int"},{"key":"533_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ab.2004.02.002","volume":"329","author":"CA Gregory","year":"2004","unstructured":"Gregory CA, Gunn WG, Peister A, Prockop DJ (2004) An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329:77\u201384. \n                    https:\/\/doi.org\/10.1016\/j.ab.2004.02.002","journal-title":"Anal Biochem"},{"key":"533_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317. \n                    https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"key":"533_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1089\/scd.2012.0637","volume":"22","author":"R Calloni","year":"2013","unstructured":"Calloni R, Cordero EAA, Henriques JAP, Bonatto D (2013) Reviewing and updating the major molecular markers for stem cells. Stem Cells Dev 22:1455\u20131476. \n                    https:\/\/doi.org\/10.1089\/scd.2012.0637","journal-title":"Stem Cells Dev"},{"key":"533_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-62703-478-4_13","volume":"1029","author":"S Das","year":"2013","unstructured":"Das S, Levasseur D (2013) Transcriptional regulatory mechanisms that govern embryonic stem cell fate. Methods Mol Biol 1029:191\u2013203. \n                    https:\/\/doi.org\/10.1007\/978-1-62703-478-4_13","journal-title":"Methods Mol Biol"},{"key":"533_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbrc.2011.11.087","volume":"417","author":"MV Bais","year":"2012","unstructured":"Bais MV, Shabin ZM, Young M et al (2012) Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. Biochem Biophys Res Commun 417:211\u2013216. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2011.11.087","journal-title":"Biochem Biophys Res Commun"},{"key":"533_CR30","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1002\/stem.1223","volume":"30","author":"J Han","year":"2012","unstructured":"Han J, Mistriotis P, Lei P et al (2012) Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells 30:2746\u20132759. \n                    https:\/\/doi.org\/10.1002\/stem.1223","journal-title":"Stem Cells"},{"key":"533_CR31","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1038\/emm.2014.28","volume":"46","author":"S-M Han","year":"2014","unstructured":"Han S-M, Han S-H, Coh Y-R et al (2014) Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Exp Mol Med 46:e101. \n                    https:\/\/doi.org\/10.1038\/emm.2014.28","journal-title":"Exp Mol Med"},{"key":"533_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2184.2011.00770.x","volume":"44","author":"DS Yoon","year":"2011","unstructured":"Yoon DS, Kim YH, Jung HS et al (2011) Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture. Cell Prolif 44:428\u2013440. \n                    https:\/\/doi.org\/10.1111\/j.1365-2184.2011.00770.x","journal-title":"Cell Prolif"},{"key":"533_CR33","doi-asserted-by":"publisher","first-page":"e40528","DOI":"10.1371\/journal.pone.0040528","volume":"7","author":"L Guo","year":"2012","unstructured":"Guo L, Qi S-T, Miao D-Q et al (2012) The roles of parathyroid hormone-like hormone during mouse preimplantation embryonic development. PLoS ONE 7:e40528. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0040528","journal-title":"PLoS ONE"},{"key":"533_CR34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1126\/science.1658941","volume":"254","author":"H J\u00fcppner","year":"1991","unstructured":"J\u00fcppner H, Abou-Samra AB, Freeman M et al (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024\u20131026","journal-title":"Science"},{"key":"533_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1474-9726.2008.00377.x","volume":"7","author":"S Zhou","year":"2008","unstructured":"Zhou S, Greenberger JS, Epperly MW et al (2008) Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7:335\u2013343. \n                    https:\/\/doi.org\/10.1111\/j.1474-9726.2008.00377.x","journal-title":"Aging Cell"},{"key":"533_CR36","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbadis.2009.01.008","volume":"1792","author":"I Bellantuono","year":"2009","unstructured":"Bellantuono I, Aldahmash A, Kassem M (2009) Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochim Biophys Acta 1792:364\u2013370. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2009.01.008","journal-title":"Biochim Biophys Acta"},{"key":"533_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","volume":"33","author":"K Stenderup","year":"2003","unstructured":"Stenderup K, Justesen J, Clausen C, Kassem M (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919\u2013926","journal-title":"Bone"},{"key":"533_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00774-010-0215-y","volume":"29","author":"S Fickert","year":"2011","unstructured":"Fickert S, Schr\u00f6ter-Bobsin U, Gross A-F et al (2011) Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent. J Bone Miner Metab 29:224\u2013235. \n                    https:\/\/doi.org\/10.1007\/s00774-010-0215-y","journal-title":"J Bone Miner Metab"},{"key":"533_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.168","author":"Q Chen","year":"2016","unstructured":"Chen Q, Shou P, Zheng C et al (2016) Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. \n                    https:\/\/doi.org\/10.1038\/cdd.2015.168","journal-title":"Cell Death Differ"},{"key":"533_CR40","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.bone.2006.06.010","volume":"39","author":"DJ Rickard","year":"2006","unstructured":"Rickard DJ, Wang F-L, Rodriguez-Rojas A-M et al (2006) Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 39:1361\u20131372. \n                    https:\/\/doi.org\/10.1016\/j.bone.2006.06.010","journal-title":"Bone"},{"key":"533_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bone.2013.02.023","volume":"55","author":"A Chandra","year":"2013","unstructured":"Chandra A, Lan S, Zhu J et al (2013) PTH prevents the adverse effects of focal radiation on bone architecture in young rats. Bone 55:449\u2013457. \n                    https:\/\/doi.org\/10.1016\/j.bone.2013.02.023","journal-title":"Bone"},{"key":"533_CR42","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1474-9726.2011.00735.x","volume":"10","author":"S Geng","year":"2011","unstructured":"Geng S, Zhou S, Glowacki J (2011) Age-related decline in osteoblastogenesis and 1\u03b1-hydroxylase\/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormone. Aging Cell 10:962\u2013971. \n                    https:\/\/doi.org\/10.1111\/j.1474-9726.2011.00735.x","journal-title":"Aging Cell"},{"key":"533_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.mce.2008.02.022","volume":"288","author":"RW Garrett","year":"2008","unstructured":"Garrett RW, Emerson SG (2008) The role of parathyroid hormone and insulin-like growth factors in hematopoietic niches: physiology and pharmacology. Mol Cell Endocrinol 288:6\u201310. \n                    https:\/\/doi.org\/10.1016\/j.mce.2008.02.022","journal-title":"Mol Cell Endocrinol"},{"key":"533_CR44","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1002\/stem.1701","volume":"32","author":"H Yao","year":"2014","unstructured":"Yao H, Miura Y, Yoshioka S et al (2014) Parathyroid hormone enhances hematopoietic expansion via upregulation of cadherin-11 in bone marrow mesenchymal stromal cells. Stem Cells 32:2245\u20132255. \n                    https:\/\/doi.org\/10.1002\/stem.1701","journal-title":"Stem Cells"},{"key":"533_CR45","doi-asserted-by":"publisher","first-page":"e87284","DOI":"10.1371\/journal.pone.0087284","volume":"9","author":"L-L Wang","year":"2014","unstructured":"Wang L-L, Chen D, Lee J et al (2014) Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice. PLoS ONE 9:e87284. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0087284","journal-title":"PLoS ONE"},{"key":"533_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00223-016-0143-5","volume":"99","author":"BL Langdahl","year":"2016","unstructured":"Langdahl BL, Ljunggren \u00d6, Benhamou CL et al (2016) Fracture rate, quality of life and back pain in patients with osteoporosis treated with teriparatide: 24-month results from the extended forsteo observational study (ExFOS). Calcif Tissue Int 99:259\u2013271. \n                    https:\/\/doi.org\/10.1007\/s00223-016-0143-5","journal-title":"Calcif Tissue Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00533-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00533-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00533-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T19:08:11Z","timestamp":1580929691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00533-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00533-0","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Antonio Casado-D\u00edaz, Gabriel Dorado, Merc\u00e8 Giner, Mar\u00eda Jos\u00e9 Montoya, Cristina Navarro-Valverde, Adolfo D\u00edez-P\u00e9rez, Jos\u00e9 Manuel Quesada-G\u00f3mez declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patients signed informed consent, in accordance with regulations of the Clinical Research Ethics Committee of Parc de Salut Mar, which approved the study. This was carried out in accordance with the terms of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}